AstraZeneca: antibody therapy lowers risk of late-stage COVID-19 symptoms

News 08/22/21, 21:17

One of the world's largest pharmaceutical companies found a novel treatment significantly reduces the chance of developing severe deadly disease symptoms on Aug. 20. AstraZeneca confirmed antibody therapy lowers the likelihood of developing extreme COVID-19 symptoms by 77%. The company cited data from a late-stage experiment that suggests this treatment could ...

End of content

No more pages to load